Serum matrix metalloproteinase-3 as a noninvasive biomarker of histological synovitis for diagnosis of rheumatoid arthritis.
about
Parallel Aspects of the Microenvironment in Cancer and Autoimmune DiseaseContinuously elevated serum matrix metalloproteinase-3 for 3 ~ 6 months predict one-year radiographic progression in rheumatoid arthritis: a prospective cohort study.Serum pharmacodynamic biomarkers for chronic corticosteroid treatment of children.Steroid therapy and renal dysfunction are independently associated with serum levels of matrix metalloproteinase-3 in patients with rheumatoid arthritis.Is synovitis detected on non-contrast-enhanced magnetic resonance imaging associated with serum biomarkers and clinical signs of effusion? Data from the Osteoarthritis Initiative.Matrix metalloproteinase-3 and the 7-joint ultrasound score in the assessment of disease activity and therapeutic efficacy in patients with moderate to severe rheumatoid arthritis.CX3CL1 promotes MMP-3 production via the CX3CR1, c-Raf, MEK, ERK, and NF-κB signaling pathway in osteoarthritis synovial fibroblasts.Joint damage is amplified in rheumatoid arthritis patients with positive thyroid autoantibodies.High rate of improvement in serum matrix metalloproteinase-3 levels at 4 weeks predicts remission at 52 weeks in RA patients treated with adalimumab.Deleterious role of hepatitis B virus infection in therapeutic response among patients with rheumatoid arthritis in a clinical practice setting: a case-control study.Presence of hepatitis B virus in synovium and its clinical significance in rheumatoid arthritis.
P2860
Q26753174-8FC430E0-C62A-4096-8B4E-45B86FA5BAF9Q36164886-91B19BDC-BE2C-44BD-A742-541CF7D8DA1FQ37181580-FF00E208-DFD7-49C3-A0DD-E432711FAA47Q38653180-F547CD56-AE5C-43D1-9921-A876EDD40684Q44681101-1CAED4F4-9690-4D62-998F-DCC72E049A68Q46321780-EECAF217-85BF-49D1-881F-FA60149CDB17Q47131296-C22C82BB-2FDF-45DF-A425-93AA821A672AQ47193354-40BDEBEE-F8B8-43FB-800D-2804CF528C8BQ50208697-5711B9CE-8A51-4133-89D4-42CE12197417Q54222708-9E64804E-22DB-43E8-9BE4-72DE01864DD7Q55379977-141AD409-501E-4F97-AC3A-146431D208FB
P2860
Serum matrix metalloproteinase-3 as a noninvasive biomarker of histological synovitis for diagnosis of rheumatoid arthritis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Serum matrix metalloproteinase ...... nosis of rheumatoid arthritis.
@ast
Serum matrix metalloproteinase ...... nosis of rheumatoid arthritis.
@en
Serum matrix metalloproteinase ...... nosis of rheumatoid arthritis.
@nl
type
label
Serum matrix metalloproteinase ...... nosis of rheumatoid arthritis.
@ast
Serum matrix metalloproteinase ...... nosis of rheumatoid arthritis.
@en
Serum matrix metalloproteinase ...... nosis of rheumatoid arthritis.
@nl
prefLabel
Serum matrix metalloproteinase ...... nosis of rheumatoid arthritis.
@ast
Serum matrix metalloproteinase ...... nosis of rheumatoid arthritis.
@en
Serum matrix metalloproteinase ...... nosis of rheumatoid arthritis.
@nl
P2093
P2860
P356
P1476
Serum matrix metalloproteinase ...... nosis of rheumatoid arthritis.
@en
P2093
Dong-Hui Zheng
Jian-Da Ma
Jing-Jing Zhou
Le-Feng Chen
Li-Juan Yang
Xiu-ning Wei
Ying-Qian Mo
P2860
P304
P356
10.1155/2014/179284
P577
2014-07-23T00:00:00Z